Stran & Company, Inc.
Stran & Company, Inc. (SWAG) Financial Performance & Income Statement Overview
Explore the financials of Stran & Company, Inc. (SWAG), including yearly and quarterly data on income, cash flow, and balance sheets.
Stran & Company, Inc. (SWAG) Income Statement & Financial Overview
Analyze Stran & Company, Inc.’s SWAG earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $28.69M | $26.99M | $20.14M | $16.69M |
Cost of Revenue | $20.21M | $18.21M | $14.19M | $11.23M |
Gross Profit | $8.48M | $8.78M | $5.95M | $5.47M |
Gross Profit Ratio | $0.30 | $0.33 | $0.30 | $0.33 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $9.02M | $9.72M | $8.14M | $6.58M |
Operating Expenses | $9.02M | $9.72M | $8.14M | $6.58M |
Total Costs & Expenses | $29.23M | $27.93M | $22.33M | $17.80M |
Interest Income | $42000.00 | $66000.00 | $64000.00 | $82000.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $250000.00 | $231000.00 | $211000.00 |
EBITDA | -$535000.00 | -$937000.00 | -$1.95M | -$896000.00 |
EBITDA Ratio | -$0.02 | -$0.03 | -$0.10 | -$0.05 |
Operating Income | -$535000.00 | -$933000.00 | -$2.18M | -$1.11M |
Operating Income Ratio | -$0.02 | -$0.03 | -$0.11 | -$0.07 |
Other Income/Expenses (Net) | $104000.00 | $350000.00 | $145000.00 | $86000.00 |
Income Before Tax | -$431000.00 | -$583000.00 | -$2.04M | -$1.02M |
Income Before Tax Ratio | -$0.02 | -$0.02 | -$0.10 | -$0.06 |
Income Tax Expense | -$38000.00 | $3000.00 | -$1000.00 | $3000.00 |
Net Income | -$393000.00 | -$586000.00 | -$2.04M | -$1.02M |
Net Income Ratio | -$0.01 | -$0.02 | -$0.10 | -$0.06 |
EPS | $0.00 | -$0.03 | -$0.11 | -$0.06 |
Diluted EPS | $0.00 | -$0.02 | -$0.11 | -$0.06 |
Weighted Avg Shares Outstanding | $0.00 | $18.60M | $18.59M | $18.59M |
Weighted Avg Shares Outstanding (Diluted) | $0.00 | $18.60M | $18.59M | $18.59M |
Over the past four quarters, Stran & Company, Inc. demonstrated steady revenue growth, increasing from $16.69M in Q2 2024 to $28.69M in Q1 2025. Operating income reached -$535000.00 in Q1 2025, maintaining a consistent -2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$535000.00, reflecting operational efficiency. Net income rose to -$393000.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan